Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma

NCT00815308 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: cetuximab (Erbitux)
DRUG: Paclitaxel
DRUG: Cisplatin
RADIATION: Radiation

Sponsor

Shandong Cancer Hospital and Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]